NCT05552755 2026-04-16
TUPELO
Recursion Pharmaceuticals Inc.
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT05630794 2026-04-13
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT06557733 2026-04-13
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05919264 2026-04-09
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
NCT06950385 2026-03-17
SERENTA
Rapamycin Holdings Inc.
Phase 3 Recruiting
NCT07463599 2026-03-11
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
Phase 1/2 Recruiting
NCT06641310 2026-02-06
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT06578637 2025-09-04
BHB-FAP
Abramson Cancer Center at Penn Medicine
Phase NA Recruiting
NCT07066046 2025-07-16
Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
Instituto do Cancer do Estado de São Paulo
Phase NA Recruiting
NCT06538402 2025-07-09
TESTIMONY
Odense University Hospital
Phase NA Recruiting
NCT06545526 2024-08-09
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Yonsei University
Phase 3 Recruiting
NCT06435533 2024-05-30
coldAPC
Universitätsklinikum Hamburg-Eppendorf
Phase NA Recruiting